Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • ARTIFICIAL INTELLIGENCE—D. Ky.: Court parses AI-use causes of action from Medicare Act determinations in Humana class action
    • ACUTE INPATIENT HOSPITALS—OIG REPORTS: Hospitals see increase in inpatient Medicare enrollees leaving before discharge
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: Surgical tech’s five-year exclusion for falsifying patient records justified
    • CLINICAL RESEARCH—FINAL RULES: Terminating National Institutes of Health Minority Biomedical Research Support Program and Rescinding the Program’s Related Regulation
    • GENERAL HEALTH CARE NEWS—D.N.M.: Court denies New Mexico OSI’s motion for summary judgment against health-sharing ministry
    • HIPAA—D. Ariz.: Patients failed to explain how HIPAA and Arizona statutes established public policy imposing duty on hospital
    • MEDICAL DEVICES—FINAL RULES: Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Pharmacogenetic Assessment System
    • MEDICAL DEVICES—FINAL RULES: Medical Devices; Immunology and Microbiology Devices; Classification of A Multiplex Respiratory Panel To Detect and Identify Emerging Respiratory Pathogen(s) and Common Respiratory Pathogens in Human Clinical Specimens
    • QUI TAM (WHISTLEBLOWER SUITS)—E.D. La.: Still-active 2018 whistleblower suit limited to core claims against wound care firm
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, CLINICAL RESEARCH—FINAL RULES: Terminating National Institutes of Health Minority Biomedical Research Support Program and Rescinding the Program’s Related Regulation, (Aug 27, 2025)

    Organizations Mentioned:National Institutes of Health

    By WK Editorial Staff

    The MBRS program prioritizes racial classifications in awarding federal funding.

    The Department of Health and Human Services (HHS), in consultation with the National Institutes of Health (NIH), is repealing the regulation relating to the Minority Biom ...

    By WK Editorial Staff

    The MBRS program prioritizes racial classifications in awarding federal funding.

    The Department of Health and Human Services (HHS), in consultation with the National Institutes of Health (NIH), is repealing the regulation relating to the Minority Biomedical Research Support (MBRS) program in compliance with Executive Order (E.O.) 14173 (Ending Illegal Discrimination and Restoring Merit-Based Opportunity) and E.O. 14151 (Ending Radical and Wasteful Government DEI Programs and Preferencing), and to abide by Supreme Court precedent. HHS remains committed to ensuring equal treatment under the law throughout its grant programs. (Final Rule, 90 Fed. Reg. 41516 (August 26, 2025)).

    Dates. This final rule is effective September 25, 2025.

    FederalRegisterIssuances: FinalRules ClinicalNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use